In vitro studies employing three-dimensional (3D) cancer organoid models derived from recto-sigmoid cancers and non recto-sigmoid cancers are warranted to understand the role of lipids in KRAS mutated signaling pathways and cancer metabolism within the 2 different tumour locations. Here, KRAS is linked to cancer.